Hu Li-Yu, Hong Chen-Jee, Tsai Shih-Jen, Shen Cheng-Che
Department of Psychiatry, Kaohsiung Veterans General Hospital, Taiwan.
School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Case Rep Psychiatry. 2022 May 16;2022:8732708. doi: 10.1155/2022/8732708. eCollection 2022.
Amisulpride is an atypical antipsychotic. It is also effective in treating depression. The potential antidepressant effect raises the concern that amisulpride can induce mania. However, reports of amisulpride-induced mania have been rare. Here, we present the case of a Taiwanese woman with a 22-year history of schizophrenia. At the age 57 years, she developed manic symptoms while on treatment with amisulpride for six weeks. She was immediately admitted to the psychiatric in-patient unit. The manic symptoms completely subsided within eight days without the administration of any mood stabilizer. Readministration of a single dose of 200 mg amisulpride during hospitalization induced the same manic symptoms, which remitted completely within 24 hours without any mood stabilizer administration.
氨磺必利是一种非典型抗精神病药物。它在治疗抑郁症方面也有效。其潜在的抗抑郁作用引发了对氨磺必利可诱发躁狂症的担忧。然而,关于氨磺必利诱发躁狂症的报道较为罕见。在此,我们报告一例有22年精神分裂症病史的台湾女性病例。57岁时,她在接受氨磺必利治疗六周后出现躁狂症状。她立即被收治入精神科住院部。在未使用任何心境稳定剂的情况下,躁狂症状在八天内完全消退。住院期间再次给予单剂量200毫克氨磺必利诱发了相同的躁狂症状,且在未使用任何心境稳定剂的情况下,症状在24小时内完全缓解。